Patent · US Active

Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responses

US9844589B2 · kind B2 · utility

2Cited by

6References

11Claims

0Family size

Assignees

Duke University · US
THE UNIVERSITY OF ALABAMA BIRMINGHAM RESEARCH FOUNDATION · US
LOS ALAMOS NATIONAL SECURITY, LLC · US

Inventors

Barton F. Haynes · Durham, US
Feng Gao · Hoover, US
Bette T. Korber · Los Alamos, US
Beatrice H. Hahn · Birmingham, US
George M. Shaw · Birmingham, US
Denise Kothe · Birmingham, US
Ying Li · Basel, CH
Julie Decker · Birmingham, US
Hua-Xin Liao · Durham, US

Key dates

Filing date	Aug 23, 2011
Grant date	Dec 19, 2017
Priority date	—
Expiry date	Aug 10, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16322
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to HIV-1 envelope polypeptides comprising the consensus envelope of SEQ ID NO: 35, compositions comprising these envelopes and methods for using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.